BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 27658528)

  • 1. Maintaining cell identity: PRC2-mediated regulation of transcription and cancer.
    Comet I; Riising EM; Leblanc B; Helin K
    Nat Rev Cancer; 2016 Dec; 16(12):803-810. PubMed ID: 27658528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astemizole arrests the proliferation of cancer cells by disrupting the EZH2-EED interaction of polycomb repressive complex 2.
    Kong X; Chen L; Jiao L; Jiang X; Lian F; Lu J; Zhu K; Du D; Liu J; Ding H; Zhang N; Shen J; Zheng M; Chen K; Liu X; Jiang H; Luo C
    J Med Chem; 2014 Nov; 57(22):9512-21. PubMed ID: 25369470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transcriptional repression by NIPP1 is mediated by Polycomb group proteins.
    Roy N; Van Eynde A; Beke L; Nuytten M; Bollen M
    Biochim Biophys Acta; 2007; 1769(9-10):541-5. PubMed ID: 17804093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycomb recruitment at the Class II transactivator gene.
    Boyd NH; Morgan JE; Greer SF
    Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer.
    Chen H; Gao S; Li J; Liu D; Sheng C; Yao C; Jiang W; Wu J; Chen S; Huang W
    Oncotarget; 2015 May; 6(15):13049-59. PubMed ID: 25944687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Multiple Facets of PRC2 Alterations in Cancers.
    Wassef M; Margueron R
    J Mol Biol; 2017 Jun; 429(13):1978-1993. PubMed ID: 27742591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.
    Orzan F; Pellegatta S; Poliani PL; Pisati F; Caldera V; Menghi F; Kapetis D; Marras C; Schiffer D; Finocchiaro G
    Neuropathol Appl Neurobiol; 2011 Jun; 37(4):381-94. PubMed ID: 20946108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting histone methyltransferase EZH2 as cancer treatment.
    Kondo Y
    J Biochem; 2014 Nov; 156(5):249-57. PubMed ID: 25179367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EZH2 as a potential target in cancer therapy.
    McCabe MT; Creasy CL
    Epigenomics; 2014 Jun; 6(3):341-51. PubMed ID: 25111487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
    Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
    Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezh2 maintains retinal progenitor proliferation, transcriptional integrity, and the timing of late differentiation.
    Zhang J; Taylor RJ; La Torre A; Wilken MS; Cox KE; Reh TA; Vetter ML
    Dev Biol; 2015 Jul; 403(2):128-38. PubMed ID: 25989023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRAJA1 is a ubiquitin ligase for the polycomb repressive complex 2 proteins.
    Zoabi M; Sadeh R; de Bie P; Marquez VE; Ciechanover A
    Biochem Biophys Res Commun; 2011 May; 408(3):393-8. PubMed ID: 21513699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of the EZH2 histone methyltransferase in cancer epigenetics.
    Simon JA; Lange CA
    Mutat Res; 2008 Dec; 647(1-2):21-9. PubMed ID: 18723033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of enhancer of zests homolog 2 in lymphoma.
    Guo SQ; Zhang YZ
    Chin Med J (Engl); 2012 Oct; 125(20):3735-9. PubMed ID: 23075734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrations of EZH2 in cancer.
    Chase A; Cross NC
    Clin Cancer Res; 2011 May; 17(9):2613-8. PubMed ID: 21367748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRC2 and SWI/SNF Chromatin Remodeling Complexes in Health and Disease.
    Kadoch C; Copeland RA; Keilhack H
    Biochemistry; 2016 Mar; 55(11):1600-14. PubMed ID: 26836503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing.
    Mozzetta C; Pontis J; Fritsch L; Robin P; Portoso M; Proux C; Margueron R; Ait-Si-Ali S
    Mol Cell; 2014 Jan; 53(2):277-89. PubMed ID: 24389103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezh1 and Ezh2 differentially regulate PSD-95 gene transcription in developing hippocampal neurons.
    Henriquez B; Bustos FJ; Aguilar R; Becerra A; Simon F; Montecino M; van Zundert B
    Mol Cell Neurosci; 2013 Nov; 57():130-43. PubMed ID: 23932971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein.
    Holland D; Hoppe-Seyler K; Schuller B; Lohrey C; Maroldt J; Dürst M; Hoppe-Seyler F
    Cancer Res; 2008 Dec; 68(23):9964-72. PubMed ID: 19047178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH2.
    Dann SG; Ryskin M; Barsotti AM; Golas J; Shi C; Miranda M; Hosselet C; Lemon L; Lucas J; Karnoub M; Wang F; Myers JS; Garza SJ; Follettie MT; Geles KG; Klippel A; Rollins RA; Fantin VR
    EMBO J; 2015 Jul; 34(13):1773-85. PubMed ID: 25979827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.